on this page
Patient eligibility
The Pharmaceutical Benefits Scheme (PBS) subsidises treatment with sonidegib and vismodegib under the National Health Act 1953, section 85 for adult patients with metastatic or locally advanced basal cell carcinoma.
Patients must be eligible for the PBS and meet the relevant restriction criteria.
The Schedule of Pharmaceutical Benefits on the PBS website outlines the restrictions for prescribing sonidegib and vismodegib.
Authority applications
Applying for initial treatment
Applications for initial authority approval to prescribe PBS-subsidised sonidegib or vismodegib to treat metastatic or locally advanced BCC can be made either in:
- real time using the Online PBS Authorities system
- writing and use HPOS Form upload
- writing and mail to PBS Complex Drugs Programs.
All written applications must include the completed:
- authority prescription form or forms
- Metastatic or locally advanced basal cell carcinoma - sonidegib or vismodegib - initial authority application form
- relevant attachments.
Applying for continuing treatment
Applications for continuing authority approval to prescribe PBS-subsidised sonidegib or vismodegib to treat metastatic or locally advanced BCC can be made either in:
- real time using the Online PBS Authorities system
- writing and use HPOS Form upload
- writing and mail to PBS Complex Drugs Programs.
All written applications must include the completed:
- authority prescription form or forms
- Metastatic or locally advanced basal cell carcinoma - sonidegib or vismodegib - continuing authority application form
- relevant attachments.
More information
Call the PBS Complex Drugs Programs enquiry line for more information.